Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2015

Open Access 01-06-2015 | Original Article

Cardiovascular remodeling during long-term nocturnal home hemodialysis

Authors: Tyler Friesen, Davinder S. Jassal, Mike Zhu, Frederick Eng, Claudio Rigatto, Navdeep Tangri, Manish M. Sood, Erin Karlstedt, Sheena Premecz, Paul Komenda

Published in: Clinical and Experimental Nephrology | Issue 3/2015

Login to get access

Abstract

Background

Cardiovascular disease is the leading cause of morbidity and mortality in patients with kidney failure. Nocturnal home hemodialysis (NHD) is a form of kidney replacement therapy whereby hemodialysis is performed for at least 6-h overnight, at least 4 days per week. Little is known about the effects of NHD on cardiovascular remodeling as assessed by transthoracic echocardiography (TTE) and cardiac magnetic resonance imaging (CMR).

Objectives

The primary objective of the study was to determine the long-term effects of NHD on cardiovascular remodeling using different imaging modalities over a one-year follow-up.

Methods and results

A total of 11 patients were included in the study (6 males, mean age 48 ± 16 years) between 2009 and 2011 inclusive at a single tertiary care center. All patients underwent TTE and CMR at baseline and after 1 year of NHD. Left ventricular mass index decreased significantly at 1 year by both TTE (152 ± 7–129 ± 8 g/m2, p < 0.05) and CMR (162 ± 4–124 ± 4 g/m2, p < 0.05). There was also a significant decrease in both left and right atrial volume as well as in right ventricular mass index over 1 year of follow-up. Diastolic dysfunction, graded from 0 to 4, improved from a baseline grade of 3.4 to 1.2 at 1-year follow-up.

Conclusions

Long-term nocturnal hemodialysis leads to favorable cardiovascular remodeling with a reduction in cavity dimensions, regression of left ventricular hypertrophy, and an improvement in diastolic function, as assessed by both TTE and CMR.
Literature
1.
go back to reference United States Renal Data System. Excerpts from USRDS 2009 annual data report. US Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis. 2010;55(Suppl 1):S1. United States Renal Data System. Excerpts from USRDS 2009 annual data report. US Department of Health and Human Services. The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Am J Kidney Dis. 2010;55(Suppl 1):S1.
2.
go back to reference Cheung AK, Samak MJ, Yan G, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study. Kidney Int. 2004;65:2380.PubMedCrossRef Cheung AK, Samak MJ, Yan G, et al. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO study. Kidney Int. 2004;65:2380.PubMedCrossRef
3.
go back to reference Levin A, Singer J, Thompson CR, et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27(3):347–54.PubMedCrossRef Levin A, Singer J, Thompson CR, et al. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis. 1996;27(3):347–54.PubMedCrossRef
4.
go back to reference Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007;298:1291–9.PubMedCrossRef Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007;298:1291–9.PubMedCrossRef
5.
go back to reference Chertow GM, Levin NW, Beck GJ, et al. In-center hemodialysis six times per week versus three times per week. N Eng J Med. 2010;363(24):2287–300.CrossRef Chertow GM, Levin NW, Beck GJ, et al. In-center hemodialysis six times per week versus three times per week. N Eng J Med. 2010;363(24):2287–300.CrossRef
6.
go back to reference Chan CT, Floras JS, Miller JA, et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002;61:2235–9.PubMedCrossRef Chan CT, Floras JS, Miller JA, et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int. 2002;61:2235–9.PubMedCrossRef
7.
go back to reference Rocco MV, Lockridge RS Jr, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the frequent Hemodialysis network nocturnal trial. Kidney Int. 2011;80:1080–91.PubMedCentralPubMedCrossRef Rocco MV, Lockridge RS Jr, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the frequent Hemodialysis network nocturnal trial. Kidney Int. 2011;80:1080–91.PubMedCentralPubMedCrossRef
8.
go back to reference Hörl WH, Cohen JJ, Harrington JT, et al. Atherosclerosis and uremic retention solutes. Kidney Int. 2004;66:1719.PubMedCrossRef Hörl WH, Cohen JJ, Harrington JT, et al. Atherosclerosis and uremic retention solutes. Kidney Int. 2004;66:1719.PubMedCrossRef
9.
go back to reference Ok E, Basnakian AG, Apostolov EO, et al. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int. 2005;68:173.PubMedCrossRef Ok E, Basnakian AG, Apostolov EO, et al. Carbamylated low-density lipoprotein induces death of endothelial cells: a link to atherosclerosis in patients with kidney disease. Kidney Int. 2005;68:173.PubMedCrossRef
10.
go back to reference Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl 2002:35–8. Levin A. Anemia and left ventricular hypertrophy in chronic kidney disease populations: a review of the current state of knowledge. Kidney Int Suppl 2002:35–8.
11.
go back to reference Muntner P, He J, Astor BC, et al. Traditional and non-traditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529.PubMedCrossRef Muntner P, He J, Astor BC, et al. Traditional and non-traditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529.PubMedCrossRef
12.
go back to reference Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis. 2003;41:403–10.PubMedCrossRef Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis. 2003;41:403–10.PubMedCrossRef
13.
go back to reference McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int. 2002;62(6):2216.PubMedCrossRef McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int. 2002;62(6):2216.PubMedCrossRef
14.
go back to reference Schwartz DI, Pierratos A, Richardson RM, et al. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease. Clin Nephrol. 2005;63:202–8.PubMedCrossRef Schwartz DI, Pierratos A, Richardson RM, et al. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease. Clin Nephrol. 2005;63:202–8.PubMedCrossRef
15.
go back to reference Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis. 2003;42:30–5.PubMedCrossRef Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis. 2003;42:30–5.PubMedCrossRef
16.
go back to reference Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.PubMedCrossRef Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18:1440–63.PubMedCrossRef
17.
go back to reference Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees tack force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35.PubMedCentralPubMedCrossRef Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees tack force on standardized protocols. J Cardiovasc Magn Reson. 2008;10:35.PubMedCentralPubMedCrossRef
18.
go back to reference Papavassiliu T, Kuhl HP, van Dockum W, et al. Accuracy of one- and two-dimensional algorithms with optimal image plane position for the estimation of left ventricular mass: a comparative study using magnetic resonance imaging. J Cardiovasc Magn Reson. 2004;6:845–54.PubMedCrossRef Papavassiliu T, Kuhl HP, van Dockum W, et al. Accuracy of one- and two-dimensional algorithms with optimal image plane position for the estimation of left ventricular mass: a comparative study using magnetic resonance imaging. J Cardiovasc Magn Reson. 2004;6:845–54.PubMedCrossRef
19.
go back to reference Pecoits-Filho R, Bucharles S, Barberato SH. Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment. Semin Dial. 2012;25(1):35–41.PubMedCrossRef Pecoits-Filho R, Bucharles S, Barberato SH. Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment. Semin Dial. 2012;25(1):35–41.PubMedCrossRef
20.
go back to reference Wachtell K, Bella JN, Rokkedal J, et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan intervention for endpoint reduction in hypertension (LIFE) Study. Circulation. 2002;105(9):1071.PubMedCrossRef Wachtell K, Bella JN, Rokkedal J, et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan intervention for endpoint reduction in hypertension (LIFE) Study. Circulation. 2002;105(9):1071.PubMedCrossRef
21.
go back to reference Okin PM, Wachtell K, Devereux RB, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA. 2006;296(10):1242.PubMedCrossRef Okin PM, Wachtell K, Devereux RB, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA. 2006;296(10):1242.PubMedCrossRef
22.
go back to reference Rials SJ, Wu Y, Xu X, et al. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation. 1997;96(4):1330.PubMedCrossRef Rials SJ, Wu Y, Xu X, et al. Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation. Circulation. 1997;96(4):1330.PubMedCrossRef
23.
go back to reference Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of Hypertension. JAMA. 2004;292(19):2350–6.PubMedCrossRef Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of Hypertension. JAMA. 2004;292(19):2350–6.PubMedCrossRef
24.
go back to reference London GM, Pannier B, Guerin AP, et al. Alterations of left ventricular Hypertrophy in and survival of patients receiving Hemodialysis: follow-up of an Interventional Study. J Am Soc Nephrol. 2001;12(12):2759–67.PubMed London GM, Pannier B, Guerin AP, et al. Alterations of left ventricular Hypertrophy in and survival of patients receiving Hemodialysis: follow-up of an Interventional Study. J Am Soc Nephrol. 2001;12(12):2759–67.PubMed
25.
go back to reference Wang AY, Lu Y, Cheung S et al. Plasma sodium and subclinical left atrial enlargement in chronic kidney disease. Nephrol Dial Transplant 2013:1–8 doi:10.1093/ndt/gfs588. Wang AY, Lu Y, Cheung S et al. Plasma sodium and subclinical left atrial enlargement in chronic kidney disease. Nephrol Dial Transplant 2013:1–8 doi:10.​1093/​ndt/​gfs588.
26.
go back to reference Tripepi G, Benedetto FA, Mallamaci F, et al. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol. 2007;18:1316–22.PubMedCrossRef Tripepi G, Benedetto FA, Mallamaci F, et al. Left atrial volume monitoring and cardiovascular risk in patients with end-stage renal disease: a prospective cohort study. J Am Soc Nephrol. 2007;18:1316–22.PubMedCrossRef
27.
go back to reference Tripepi G, Benedetto FA, Mallamaci F, et al. Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens. 2006;24:1173–80.PubMedCrossRef Tripepi G, Benedetto FA, Mallamaci F, et al. Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens. 2006;24:1173–80.PubMedCrossRef
28.
go back to reference Atar I, Konas D, Açikel S, et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol. 2006;106(1):47.PubMedCrossRef Atar I, Konas D, Açikel S, et al. Frequency of atrial fibrillation and factors related to its development in dialysis patients. Int J Cardiol. 2006;106(1):47.PubMedCrossRef
29.
go back to reference Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202.PubMedCrossRef Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194–202.PubMedCrossRef
30.
go back to reference Paneni F, Gregori M, Ciavarella GM, et al. Right ventricular dysfunction in patients with end-stage renal disease. Am J Nephrol. 2010;32:432–8.PubMedCrossRef Paneni F, Gregori M, Ciavarella GM, et al. Right ventricular dysfunction in patients with end-stage renal disease. Am J Nephrol. 2010;32:432–8.PubMedCrossRef
Metadata
Title
Cardiovascular remodeling during long-term nocturnal home hemodialysis
Authors
Tyler Friesen
Davinder S. Jassal
Mike Zhu
Frederick Eng
Claudio Rigatto
Navdeep Tangri
Manish M. Sood
Erin Karlstedt
Sheena Premecz
Paul Komenda
Publication date
01-06-2015
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2015
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-0992-z

Other articles of this Issue 3/2015

Clinical and Experimental Nephrology 3/2015 Go to the issue